Paulien Ravenstijn

4PUBLICATIONS
40CO-AUTHORS
GlycoconjugatesInnate immunityMolecular targetsApplications in health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 06, 2026
Clinical Pharmacology and Translational Science Considerations in the Development of Dual-Payload Antibody Drug Conjugates.

|Jan 23, 2025
First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors.

Anthony El-Khoueiry, Omar Saavedra, Jacob Thomas

|Nov 12, 2024
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas.

Won Seog Kim, Jake Shortt, Pier Luigi Zinzani

|May 16, 2024
Translating real-world evidence/real-world data.

Paulien Ravenstijn

Pageof 1

Frequent Collaborators

2 joint publications

Michael Emig

1 joint publications

Won Seog Kim

1 joint publications

Jake Shortt

1 joint publications

Pier Luigi Zinzani